Skip to content
Ask
← Funding

Massachusetts · Nonprofit

OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION

OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION (Massachusetts) receives grants from 17 organizations whose IRS filings report $943,553 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($546,710). 10 of them have funded it in more than one year, and 86% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2024
$1.6M
Funders on record
17
Grants received
$944k
Net assets
$3.0M
10/17 repeat funderspeak grant-dependency 20%
01What it does

What Ocular Immunology and Uveitis Foundation does

Mission

The Ocular Immunology and Uveitis Foundation is dedicated to improving the diagnosis and treatment and finding the causes and cures of uveitis and other ocular inflammatory diseases, increase awareness of uveitis amoung health professionals and the public, and support individuals and families affected by the disease.

As stated on its FY2024 Form 990.

Programs

  1. Various research studies and development to promote and carry out scientific and medical research in the field of diseases of the eye.

    $123,381 spent
    28% of program spending

  2. Physician education conference: a comprehensive coverage of new and emerging developments in the subspecialties of cornea, glaucoma, cataract & refractive surgery, oculoplastics, uveitis and infectious disease. The faculty consisted of nineteen ophthalmologists. Physicians from all over new england attended the conference.

    $267,600 spent$40,000 earned by the program
    60% of program spending

  3. Support group programs, consists generally of group speakers, educational and support resources.

    $56,847 spent
    13% of program spending

The 3 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $447,828.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($1.1M) Expenses 100 ($1.3M) Net assets 100 ($1.6M)2018 Revenue 107 ($1.2M) Expenses 110 ($1.5M) Net assets 74 ($1.2M)2019 Revenue 56 ($615k) Expenses 59 ($781k) Net assets 67 ($1.1M)2020 Revenue 48 ($534k) Expenses 42 ($551k) Net assets 74 ($1.2M)2021 Revenue 61 ($676k) Expenses 49 ($651k) Net assets 79 ($1.2M)2022 Revenue 66 ($734k) Expenses 56 ($734k) Net assets 64 ($1.0M)2023 Revenue 148 ($1.6M) Expenses 53 ($705k) Net assets 133 ($2.1M)2024 Revenue 141 ($1.6M) Expenses 54 ($707k) Net assets 190 ($3.0M)
'17'18'19'20'21'22'23'24
Revenue (141)Expenses (54)Net assets (190)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2022 to 2023, from $1.1M to $2.2M (+107%).

$1.8M
$1.3M
$1.1M
$1.2M
$1.3M
$1.1M
$2.2M
$3.0M
'17'18'19'20'21'22'23'24
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

83% of OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION’s revenue is contributions — more donation-reliant than the typical peer (51% for the typical peer).

This organization
Typical peer · 8,611 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 5 of the last 8 reported years ran a deficit.

−$214k
’17
−$276k
’18
−$166k
’19
−$17k
’20
$25k
’21
−$235
’22
$934k
’23
$859k
’24
21
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

'17'18'19'20'21'22'23'24
Listed1113131313141313
Joined·+3+0+0+0+1+1+1
No longer listed·1000021
03Who funds it

Who funds it, year by year

2017 → 2023: the base broadened from 2 funders to 7 funders, grant income rose $7k → $119k.

Funder
'17
'18
'19
'20
'21
'22
'23
'24*
'25*
total
funders
2
6
6
6
4
6
7
4
2

8 of 17 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 86% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION leans on a few funders — its largest provides 58% of grant income and the top three 81%; half comes from just 1 funder.

the vertical line marks half of all grant income — 1 funder to its left

86% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION.

58%
largest funder
81%
top three
~3
effective funders

Largest funder’s share by year: 2017 85% · 2018 54% · 2019 60% · 2020 76% · 2021 68% · 2022 66% · 2023 63% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

42% of OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION's funders are still giving 3 years after their first grant; 59% give in more than one year at all.

first grant+1y+2y+3y+4y+5y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

86% of OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $133k that is directly attributable, 80% of it comes from funders outside Massachusetts, across 6 states.

NH
NY
MA
CT
CO
FL

In-state vs out-of-state, by year

’17
’18
’19
’20
’21
’22
’23
Massachusetts out of state home

Funder states come from each funder’s own filing. $810k arriving through sponsors registered in 8 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION runs a healthier operating margin than three-quarters of the 8,121 health nonprofits its size.

Operating margin55% · top quartile
Months of reserve21.4mo · top quartile
Revenue growth (annualized)5% · below the median

this organization peer median middle 50% of peers· 8,121 health nonprofits $1M–$10M, FY2024

Organizations like OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Massachusetts

New England Ophthalmological Society Inc76%Schepens Eye Research Institute Inc75%Foundation of the Massachusetts Eye and Ear Infirmary Inc75%The Boston Foundation for Sight Inc75%Center for Eye Research and Education Inc74%Nuttall Ornithological Club Inc73%Frias Family Foundation73%Children's Urological Foundation Inc72%

Nationally

New England Ophthalmological Society Inc76%Nevada Vision Foundation76%Unite for Sight Inc76%Eye Foundation of America Inc75%The Macula Foundation Inc75%Fund for Ophthalmic Knowledge Inc75%Dean McGee Eye Institute Foundation75%United Opticians Association Inc75%
05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

63% of spending goes to programs.

Program 63%Management 10%Fundraising 26%

Governance

13
board members
100%
independent
✓Conflict-of-interest policy✓Whistleblower policy✓Document retention✓Board reviewed the 990✓Audited financials

Public support

84%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 1 state

MA

Part of a family of 1 related entity

  • Massachusetts Eye Research and Surgery Institute · corp_trust

Screen this organization

A dated, signed PDF of the compliance screen for OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION?
OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION (Massachusetts) receives grants from 17 organizations whose IRS filings report $943,553 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($546,710). 10 of them have funded it in more than one year, and 86% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION have?
IRS filings report 17 organizations giving $943,553 in grants to OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION, 10 of which have funded it in more than one year.
Who is the largest funder of OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION?
FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $546,710 in grants. The full list of funders is on this page.
How can an organization like OCULAR IMMUNOLOGY AND UVEITIS FOUNDATION find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Massachusetts. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds Ocular Immunology and Uveitis →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 17 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing